Concepedia

Luis Nevárez Ruiz

LN

Statistics

Publications

6

Citations

603

H-Index

6

Active since

2021

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Universidad Europea de Madrid

University of Michigan

Steno Diabetes Centers

German Centre for Cardiovascular Research

Luis Nevárez Ruiz is an author at Indiana University – Purdue University Indianapolis specializing in pharmacotherapy, pharmacology, and chronic kidney disease.

Publications per year

2021–2025

6

Publications

6

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

, , +17

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz et al. · Diabetes Care · 2021 · 190 citations · Full text

, , +16

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

, , +17

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

Julio Rosenstock, Stanley H. Hsia, Luis Nevárez Ruiz et al. · New England Journal of Medicine · 2025 · 80 citations

, , +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

, , +17

1–5 of 6